Patents by Inventor Jianwen Tang

Jianwen Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200056261
    Abstract: Provided is a device for continuously decomposing a rare earth concentrate ore. The device includes a body, a bidirectional propeller and a driving assembly. The body has a material inlet, two liquid inlets and two exhaust gas outlets disposed at the top of the body, two material outlets disposed at the bottom of the body and a heat preservation chamber provided inside a side wall of the body. The bidirectional propeller is provided in the body and extends along a length direction of the body. The driving assembly is connected to the rotating shaft.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 20, 2020
    Inventors: Jianwen TANG, Guoshan DU, Pengfei XIAN, Shuang QIU, Wenlong ZHOU, Bo QIN
  • Publication number: 20200056265
    Abstract: Provided are a method and a system for processing a rare earth concentrate ore. The method comprises (1) mixing the rare earth concentrate ore and concentrated sulfuric acid, thereby obtaining a mixed slurry and a first fluorine-containing gas; (2) mixing the mixed slurry and an initiator liquid for acidolysis, thereby obtaining a clinker and a second fluorine-containing gas; (3) subjecting the clinker to leaching with water, thereby obtaining a leached slurry; (4) subjecting the leached slurry to a solid-liquid separation, thereby obtaining a filtrate and a leached slag, and recycling the leached slag to step (2) for acidolysis again.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 20, 2020
    Inventors: Jianwen TANG, Guoshan DU, Pengfei XIAN, Shuang QIU, Wenlong ZHOU, Bo QIN
  • Publication number: 20190387295
    Abstract: An optical line terminal (OLT) device virtualization method and a related device, the method including creating a plurality of virtual OLT systems on an OLT device, and determining system resources of each of the plurality of virtual OLT systems according to a preset rule. The system resources include a physical resource and a logical resource, and physical resources and logical resources of the plurality of virtual OLT systems are different from each other.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 19, 2019
    Inventors: Yanhua Zhang, Zengzhan Wei, Daoming Wang, Jianwen Tang
  • Publication number: 20120263647
    Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.
    Type: Application
    Filed: December 16, 2011
    Publication date: October 18, 2012
    Applicant: diaDexus, Inc.
    Inventors: Jackie Papkoff, Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Laura Corral, Iris Simon, Muriel Kmet, Jianwen Tang
  • Patent number: 8080650
    Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: December 20, 2011
    Assignee: diaDexus, Inc.
    Inventors: Jackie Papkoff, Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Laura Corral, Iris Simon, Muriel Kmet, Jianwen Tang
  • Publication number: 20090220424
    Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.
    Type: Application
    Filed: January 15, 2009
    Publication date: September 3, 2009
    Inventors: Jackie Papkoff, Glenn Pilkington, Gilbert-Andre Keller, Weniu Li, Laura Corral, Iris Simon, Muriel Kmet, Jianwen Tang
  • Patent number: 7479546
    Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro 104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro 104 antibody, as well as an expression vector comprising the isolated'l nucleic acid. Also provided are cells that produce the anti-Pro 104 antibodies. The invention encompasses a method of producing the anti-Pro 104 antibodies. Other aspects of the invention are a method of killing a Pro 104-expressing cancer cell, comprising contacting the cancer cell with an antiPro104 antibody and a method of alleviating or treating a Pro 104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro 104 antibody to the mammal.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: January 20, 2009
    Assignee: diaDexus, Inc.
    Inventors: Jackie Papkoff, Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Laura Corral, Iris Simon, Muriel Kmet, Jianwen Tang